Aptah Biosciences Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3M

  • Investors
  • 6

Aptah Biosciences General Information

Description

Developer of novel RNA therapies designed for targeting cancer and neurodegenerative diseases. The company uses a process to create new synthetic and biological molecules based on deoxyribonucleic acid to achieve connection to a specific target in a few days rather than months, enabling medical professionals to reduce the time, costs, and risks of discovery and to make them widely available.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 930 MBC Brittan Avenue
  • Suite 370
  • San Carlos, CA 94070
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 930 MBC Brittan Avenue
  • Suite 370
  • San Carlos, CA 94070
  • United States
+1 (650)

Aptah Biosciences Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aptah Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 24-Mar-2025 $3M Completed Clinical Trials - General
6. Later Stage VC (Series A) 14-Aug-2023 Completed Clinical Trials - General
5. Accelerator/Incubator 26-Aug-2021 Completed Clinical Trials - General
4. Accelerator/Incubator 14-Aug-2019 Completed Clinical Trials - General
3. Accelerator/Incubator 01-Jan-2019 Completed Clinical Trials - General
2. Accelerator/Incubator Completed Clinical Trials - General
1. Accelerator/Incubator Completed Clinical Trials - General
To view Aptah Biosciences’s complete valuation and funding history, request access »

Aptah Biosciences Patents

Aptah Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4652278-A1 Polynucleotide compositions and methods for treatment of cancer Pending 18-Jan-2023
US-20260085315-A1 Polynucleotide compositions and methods for treatment of cancer Pending 18-Jan-2023
WO-2024155740-A1 Polynucleotide compositions and methods for treatment of cancer Inactive 18-Jan-2023
EP-4652277-A1 Polynucleotide compositions and methods for treatment of neurodegenerative diseases Pending 18-Jan-2023
US-20260022377-A1 Polynucleotide compositions and methods for treatment of neurodegenerative diseases Pending 18-Jan-2023 C12N15/113
To view Aptah Biosciences’s complete patent history, request access »

Aptah Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aptah Biosciences Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Financiadora de Estudos e Projetos Government
MBC BioLabs Accelerator/Incubator Minority
Vesper (Biotechnology) Accelerator/Incubator Minority
Startup OutReach Brasil Accelerator/Incubator
Biominas Brasil Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Aptah Biosciences FAQs

  • When was Aptah Biosciences founded?

    Aptah Biosciences was founded in 2018.

  • Where is Aptah Biosciences headquartered?

    Aptah Biosciences is headquartered in San Carlos, CA.

  • What is the size of Aptah Biosciences?

    Aptah Biosciences has 10 total employees.

  • What industry is Aptah Biosciences in?

    Aptah Biosciences’s primary industry is Drug Discovery.

  • Is Aptah Biosciences a private or public company?

    Aptah Biosciences is a Private company.

  • What is Aptah Biosciences’s current revenue?

    The current revenue for Aptah Biosciences is .

  • How much funding has Aptah Biosciences raised over time?

    Aptah Biosciences has raised $8M.

  • Who are Aptah Biosciences’s investors?

    Financiadora de Estudos e Projetos, MBC BioLabs, Vesper (Biotechnology), Startup OutReach Brasil, and Biominas Brasil are 5 of 6 investors who have invested in Aptah Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process